- Home
- ENLV vs UTSI Comparison
ENLV vs UTSI Comparison
Compare ENLV & UTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- UTSI
- Stock Information
- Founded
- ENLV 2005
- UTSI 1991
- Country
- ENLV Israel
- UTSI China
- Employees
- ENLV N/A
- UTSI N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- UTSI Telecommunications Equipment
- Sector
- ENLV Health Care
- UTSI Telecommunications
- Exchange
- ENLV Nasdaq
- UTSI Nasdaq
- Market Cap
- ENLV 23.7M
- UTSI 24.9M
- IPO Year
- ENLV 1995
- UTSI 2000
- Fundamental
- Price
- ENLV $1.07
- UTSI $2.61
- Analyst Decision
- ENLV Strong Buy
- UTSI
- Analyst Count
- ENLV 2
- UTSI 0
- Target Price
- ENLV $10.00
- UTSI N/A
- AVG Volume (30 Days)
- ENLV 1.2M
- UTSI 7.6K
- Earning Date
- ENLV 08-29-2025
- UTSI 08-29-2025
- Dividend Yield
- ENLV N/A
- UTSI N/A
- EPS Growth
- ENLV N/A
- UTSI N/A
- EPS
- ENLV N/A
- UTSI N/A
- Revenue
- ENLV N/A
- UTSI $9,793,000.00
- Revenue This Year
- ENLV N/A
- UTSI N/A
- Revenue Next Year
- ENLV N/A
- UTSI N/A
- P/E Ratio
- ENLV N/A
- UTSI N/A
- Revenue Growth
- ENLV N/A
- UTSI N/A
- 52 Week Low
- ENLV $0.81
- UTSI $1.84
- 52 Week High
- ENLV $2.10
- UTSI $3.22
- Technical
- Relative Strength Index (RSI)
- ENLV 41.31
- UTSI 56.29
- Support Level
- ENLV $1.01
- UTSI $2.20
- Resistance Level
- ENLV $1.13
- UTSI $2.85
- Average True Range (ATR)
- ENLV 0.13
- UTSI 0.11
- MACD
- ENLV -0.02
- UTSI 0.02
- Stochastic Oscillator
- ENLV 8.04
- UTSI 63.08
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About UTSI UTStarcom Holdings Corp.
UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.